Finance

Beta
Lists
HQ1:FRA
Oruka Therapeutics Inc
€57.50
+5.50%
(+3.00) 1D
Jun 10, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HQ1...
Open
€57.50
High
€57.50
Low
€57.50
Mkt. cap
3.86B
Avg. vol.
3.00
Volume
0.00
52-wk high
€68.50
52-wk low
€9.20
No. of employees
68
Open
€57.50
High
€57.50
Low
€57.50
Mkt. cap
3.86B
Avg. vol.
3.00
Volume
0.00
52-wk high
€68.50
52-wk low
€9.20
No. of employees
68
News stories
From sources across the web
About Oruka Therapeutics Inc
CEO-
Employees68
Founded2024
HeadquartersWestminster, Colorado, United States
SectorBiotechnology
Websiteorukatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
24.09M
28.99M
27.64M
29.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.34M
5.12M
6.79M
7.29M
Operating expense
28.43M
34.10M
34.43M
36.43M
Total operating expenses
28.43M
34.10M
34.43M
36.43M
Operating income
-28.43M
-34.10M
-34.43M
-36.43M
Other non operating income
-2.00K
-4.00K
-1.00K
8.00K
EBT including unusual items
-24.57M
-30.28M
-29.58M
-31.82M
EBT excluding unusual items
-24.57M
-30.28M
-29.58M
-31.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.57M
-30.28M
-29.58M
-31.82M
Net profit margin
-
-
-
-
Earnings per share
-0.46
-0.55
-0.45
-0.48
Interest and investment income
3.86M
3.83M
4.85M
4.61M
Interest expense
-
-
-
-
Net interest expenses
3.86M
3.83M
4.85M
4.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.41M
-34.08M
-34.40M
-36.39M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer